NeuroTech Harbor: Our nation's first equitech ecosystem for neuromedical technologies
Project Number3U54EB033664-03S5
Contact PI/Project LeaderSARMA, SRIDEVI V. Other PIs
Awardee OrganizationJOHNS HOPKINS UNIVERSITY
Description
Abstract Text
PROJECT SUMMARY OVERALL
The two aims of NeuroTech Harbor are: (AIM 1) to accelerate early development of the most promising
neuromedical solutions, and (AIM 2) to increase the number of women & URM innovators through outreach and
education, and to improve equity and accessibility of neuromedical solutions. NeuroTech Harbor (NTH), led by
Johns Hopkins and Howard Universities, will accelerate the development of highly promising solutions to improve
neurological health for all. Solutions for all means also for the underserved, often synonymous with minority
groups. Diverse innovators should sit at the table on day one, but very few minority entrepreneurs exist. To
address these inequities, we will build NTH with an Equitech philosophy, which is the belief that diversity of
teams, leadership, and perspectives is a force multiplier to fuel innovation, producing solutions accessible to all
communities. Hopkins & Howard are uniquely positioned to realize this vision. Hopkins brings a foundation of
researchers, prestigious research centers, and programs and has a translation track record ($3B invested in
start-ups in the last 7 years). Howard complements this with a large pipeline of aspiring under-represented
minority (URM) innovators both within and outside the Howard community. Howard has nurtured this community
with early-stage mentorship, a successful incubator program, and recently received a $17M grant to create a
Center for Entrepreneurship aimed at building resources and support for Black business owners across the
country.
NTH will solicit proposals from innovators nationwide addressing pressing problems. Although the areas
supported will be broad, covering all participating NIH Institutes and Centers, the expertise of NTH will be
inclusive but focusing on Neuroprosthesis (cortical, spinal, peripheral, vision, and auditory), Brain Machine
Interface, Neuro Sensors and Devices, Neuro Informatics, Neuromodulation, and Mental Health. For funded
projects, resources will be provided, and a dream team of specialists will offer mentorship and tools to guide
successful translation to first-in-human prototype. Specialists will be drawn from a diverse Steering Committee,
Advisory Board, and Consultant Network, composed of highly regarded clinicians, scientists, technologists,
commercialization experts, and patient advocates. To expand diversity amongst innovators, NTH has formed
strategic Outreach Partnerships with access to Historically Black Colleges and Universities and Minority Serving
Institutions across the nation. We have created an NTH Institute, a center for innovator leadership development
to educate innovators in business development, translation and project management. Importantly, our needs
assessments will be guided by the principles of equity and accessibility for all communities and will include the
input of underserved stakeholders. Our 5-year goals are to (i) solicit over 500 applications and launch 45 projects,
where at least 15 have 1 woman or URM innovator on the team, and (ii) blaze a trail to alleviate suffering from
neurological conditions for all, including the underserved...the Equitech way.
Public Health Relevance Statement
NeuroTech Harbor (NTH) led by Johns Hopkins and Howard Universities will gather innovators, expert mentors,
and resource providers to accelerate the development of highly promising solutions to improve neurological
health for all. To address the lack of women and under-represented minority innovators, it will create the nation's
first incubator ecosystem with an Equitech philosophy - the belief that diversity of teams, leadership, and
perspectives is a force multiplier to fuel innovation producing solutions accessible to all communities.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AccelerationAddressAdvocateAreaAuditoryAwardBeliefBlack raceBusinessesCollaborationsColorCommunitiesCountryDevelopmentDevicesDreamsEcosystemEducationEducation and OutreachEngineeringEnsureEntrepreneurshipEquityEvaluationFacultyFoundationsFundingGoalsGrantHealthHistorically Black Colleges and UniversitiesHomeIncubatorsInequityInstitutionInternationalInvestmentsLaboratoriesLatinxLeadLeadershipLegal patentMarketingMedicalMental HealthMentorsMentorshipMinorityMinority GroupsMinority-Serving InstitutionNeeds AssessmentNeurologicPatientsPeripheralPhilosophyPhysicsPlayPositioning AttributePrivatizationProfessional OrganizationsProviderResearchResearch PersonnelResourcesScientistSpecialistSpinalTechnologyTranslationsUnderrepresented MinorityUnited States National Institutes of HealthUniversitiesVisionWomanbrain machine interfacecommercializationexperiencefirst-in-humanimprovedinnovationleadership developmentneuralneuroinformaticsneuroprosthesisneuroregulationoutreachprogramsprospectiveprototyperecruitresponsesensorsuccesstool
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
001910777
UEI
FTMTDMBR29C7
Project Start Date
30-September-2022
Project End Date
30-June-2027
Budget Start Date
09-September-2024
Budget End Date
30-June-2025
Project Funding Information for 2024
Total Funding
$227,202
Direct Costs
$224,482
Indirect Costs
$2,720
Year
Funding IC
FY Total Cost by IC
2024
National Eye Institute
$113,601
2024
National Institute of Neurological Disorders and Stroke
$113,601
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 3U54EB033664-03S5
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3U54EB033664-03S5
Patents
No Patents information available for 3U54EB033664-03S5
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3U54EB033664-03S5
Clinical Studies
No Clinical Studies information available for 3U54EB033664-03S5
News and More
Related News Releases
No news release information available for 3U54EB033664-03S5
History
No Historical information available for 3U54EB033664-03S5
Similar Projects
No Similar Projects information available for 3U54EB033664-03S5